No Detail Found!

Outcomes after Surgical Resection of Hilar cholangiocarcinoma.

Author(s)
Faisal Saud Dar Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan
Muhammad Atiq Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan
Neelam Shahzadi Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan
Seemab Khalid Ainy Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan
Atif Rana Radiology, Shifa International Hospital, Islamabad, Pakistan
Abu Bakar Hafeez Bhatti Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan
Abstract
Objective: To report long term outcomes after surgical resection of hilar cholangiocarcinoma (hCCA). Study Design: Cohort study. Place and Duration of Study: Department of Liver Transplant and Hepatopancreaticobiliary Surgery, Shifa International Hospital, Islamabad, Pakistan, from October 2011 to April 2018. Methodology: A prospective review of maintained database of patients who underwent surgical resection for hCCA was performed. A total of 24 patients were included. Outcome was assessed, based upon 90-day morbidity and mortality, 5-year recurrence-free survival (RFS) and overall survival (OS). Results: Median age was 49 (23-73) years. Male to female ratio was 1.4:1. Median CA 19-9 level was 113 (2-1200) U/ml. Nine patients (37.5%) underwent right hepatectomy, six had right trisectionectomy (25%), three had central hepatectomy (12.5%) and left hepatectomy (12.5%) each, while three (12.5%) had other surgical procedures. In addition, two (8.3%) patients required portal vein resection and reconstruction. Median blood loss was 1350 (100-2000) ml. Median ICU stay was 4 (2-13) days, while hospital stay was 10 (6-32) days. Sixteen (66.7%) patients experienced at least one morbidity within 90 days, while 90-day mortality was 1/24 (4.1%). The overall recurrence rate was 6/18 (33.4%) and mortality was 9/18 (50%). The actuarial 5-year RFS was 60% and OS was 39%. Conclusion: hCCA remains a technically challenging surgical problem. Outcomes comparable to international standards can be achieved in experienced centres.
Publication Details
Page(s) 874-877
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 9, Year: 2019

Request the full text from PASTIC

0

Citations

0

Downloads

89

Views